Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Australia's drug prices to drop by up to 50%
Asia-Pacific
More than 2,000 medicine brands treating common conditions will drop in price for millions of Australians from October 1, according to the Australian government’s Department of Health.   6 September 2016
Alvogen launches Copaxone generic
Big Pharma
Pharmaceutical company Alvogen has launched the first generic version of Copaxone in Europe under the name Remurel.   6 September 2016
Big Pharma
The Francis Crick Institute, Europe’s biggest biomedical research institute, has opened in London.   5 September 2016
Asia
Chugai Pharmaceutical and Fuji Pharma have entered into an agreement to transfer the rights to the manufacture and marketing of cancer drug Vesanoid in Japan.   5 September 2016
Americas
Neos Therapeutics has filed a patent infringement suit against Teva, and its subsidiary Actavis, for allegedly infringing a number of its patents.   2 September 2016
Americas
Japanese pharmaceutical company Otsuka Pharmaceutical has filed a complaint against Indian company Ajanta Pharma for allegedly infringing a patent for its bipolar and schizophrenia medication, Abilify (aripiprazole).   2 September 2016
Americas
Dublin-based pharmaceutical company Allerganhas revealed that its subsidiaries, Forest Laboratories and Adamas Pharmaceuticals, have entered into a settlement agreement with Amneal Pharmaceuticals.   1 September 2016
Americas
The University of Minnesota has sued Gilead Sciences for allegedly infringing the university’s patent by selling drugs containing sofosbuvir.   1 September 2016
Americas
UK-based company AstraZeneca will have to pay $5.5 million to resolve a bribery case after allegedly falsely rewarding healthcare officials in China and Russia.   31 August 2016
Americas
Diagnostics company Alere has filed a complaint against Abbott in the Delaware Chancery Court in an attempt to compel Abbott to fulfil its obligations surrounding the companies’ merger agreement.   31 August 2016